Hims & Hers Shares Volatile Amidst Regulatory Setbacks and New Product Launch
Telehealth company Hims & Hers Health (HIMS) is navigating a chaotic week defined by a sharp regulatory pivot and a strategic expansion into oncology screening. The stock has seen significant volatility following the abrupt withdrawal […]